おすすめの製品
詳細
Provides means to quickly and simply label antibodies or other proteins with fluorescein. Direct labeling of the primary antibody eliminates the need for a secondary antibody, and results in a lower background and overall higher signal-to-noise ratio. Each kit is sufficient to perform at least five conjugations on proteins of 100 µg to 2.5 mg each.
構成
Fluorescein (five vials), Carbonate Buffer Concentrate, DMF Solvent, PBS Buffer Concentrate, and a user protocol.
警告
Toxicity: Multiple Toxicity Values, refer to MSDS (O)
原理
The Calbiochem FITC Labeling Kit provides a means of quickly and simply labeling antibodies or other proteins with fluorescein. FITC-antibody conjugates are useful in many applications, such as flow cytometry and immunocytochemistry. Other proteins such as steroids may also be labeled with FITC. Direct labeling of the primary antibody eliminates the need for a secondary antibody, and therefore results in a lower background and an overall higher signal to noise ratio.
調製ノート
Antibody/Protein Preparation: Add 10 ml of carbonate buffer concentrate to 990 ml of distilled water and dialyze antibody in buffer overnight.
アナリシスノート
1. Read the absorbance of the FITC-antibody conjugate at two wavelengths: 280 nm and 495 nm. Use the 1X PBS/0.1%NaN3 as the spectrophotometric blank. Optimal absorbance readings of the conjugated protein will be within the range of 0.2-1.2 ABS.
2. Using the two absorbance readings, calculate the F/P molar ratio of the FITC/Protein conjugate using the following equation:<div class="Bio_doc_image">Figure 1: F/P Molar Ration
</div>
3. There are 2 equations used for the determination of the concentration of the FITC-antibody conjugate. If the protein used for conjugation was IgG, use the following equation to estimate the concentration of the labeled antibody:<div class="Bio_doc_image"><p class="title">Figure 2: Concentration of FITC-IgG
</div>If the protein conjugated was not IgG, use the following equation to estimate the concentration of conjugated protein:<div class="Bio_doc_image">Figure 3: Concentration of FITC-Protein
</div>Where E0.1% is the A280 reading of a 1 mg/ml solution of the unconjugated protein, as measured in a cuvette of 1 cm path length.
2. Using the two absorbance readings, calculate the F/P molar ratio of the FITC/Protein conjugate using the following equation:<div class="Bio_doc_image">Figure 1: F/P Molar Ration
</div>
3. There are 2 equations used for the determination of the concentration of the FITC-antibody conjugate. If the protein used for conjugation was IgG, use the following equation to estimate the concentration of the labeled antibody:<div class="Bio_doc_image"><p class="title">Figure 2: Concentration of FITC-IgG
</div>If the protein conjugated was not IgG, use the following equation to estimate the concentration of conjugated protein:<div class="Bio_doc_image">Figure 3: Concentration of FITC-Protein
</div>Where E0.1% is the A280 reading of a 1 mg/ml solution of the unconjugated protein, as measured in a cuvette of 1 cm path length.
その他情報
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
法的情報
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
シグナルワード
Danger
危険有害性情報
危険有害性の分類
Eye Irrit. 2 - Repr. 1B - Resp. Sens. 1 - Skin Sens. 1
保管分類コード
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
毒物及び劇物取締法
キットコンポーネントの情報を参照してください
PRTR
キットコンポーネントの情報を参照してください
消防法
キットコンポーネントの情報を参照してください
労働安全衛生法名称等を表示すべき危険物及び有害物
キットコンポーネントの情報を参照してください
労働安全衛生法名称等を通知すべき危険物及び有害物
キットコンポーネントの情報を参照してください
カルタヘナ法
キットコンポーネントの情報を参照してください
Jan Code
キットコンポーネントの情報を参照してください
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Infection and immunity, 78(5), 1841-1849 (2010-02-24)
Helicobacter pylori chronically infects the gastric mucosa, where it can be found free in mucus, attached to cells, and intracellularly. H. pylori requires iron for growth, but the sources of iron used in vivo are unclear. In previous studies, the
Infection and immunity, 79(8), 3106-3116 (2011-05-18)
Helicobacter pylori persistently colonizes humans, causing gastritis, ulcers, and gastric cancer. Adherence to the gastric epithelium has been shown to enhance inflammation, yet only a few H. pylori adhesins have been paired with targets in host tissue. The alpAB locus
Frontiers in oncology, 9, 1074-1074 (2019-11-12)
Background and Objective: Matricellular proteins modulate the micro environment of tumors and are recognized to contribute to tumor cell invasion and dissemination. The cysteine-rich angiogenic inducer 61 (CYR61) is upregulated in mesenchymal transformed and invasive breast cancer cells. CYR61 correlates
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)